Chest
Volume 156, Issue 5, November 2019, Pages 878-886
Journal home page for Chest

Original Research: Critical Care
Percentage of Time in Range 70 to 139 mg/dL Is Associated With Reduced Mortality Among Critically Ill Patients Receiving IV Insulin Infusion

https://doi.org/10.1016/j.chest.2019.05.016Get rights and content
Under a Creative Commons license
open access

Background

In addition to hyperglycemia, hypoglycemia, and glycemic variability, reduced time in targeted blood glucose range (TIR) is associated with increased risk of death in critically ill patients. This relation between TIR and mortality may be confounded by diabetic status and antecedent glycemic control.

Methods

This study retrospectively analyzed critically ill patients managed with the same IV insulin protocol at multiple centers. The percentage of TIR between 70 and 139 mg/dL was calculated. Patients with diabetic ketoacidosis, patients who had < 10 blood glucose readings, and patients with repeat admissions were excluded. The highest recorded glycosylated hemoglobin value in the preceding 3 months or up to 1 month following admission were used as a surrogate for the patient’s preexisting glucose control. Stratified regression analyses were performed for 30-day mortality, with covariates of age, sex, TIR ≥ 80%, Acute Physiology Score, and Charlson Comorbidity Index.

Results

A total of 9,028 patients, 53.2% of whom had diabetes, were studied. Median TIR was 84.1% for nondiabetic patients and 64.5% for patients with diabetes. Mortality was lower in those with TIR > 80% compared with those with TIR ≤ 80% (12.4% vs 19.2%; P < .001). TIR > 80% was independently associated with reduced mortality in nondiabetic patients (OR, 0.52; P < .001), patients with diabetes (OR, 0.69; P = .001), and patients with well-controlled disease (OR, 0.50; P < .001) but not in patients with poorly controlled disease (OR, 0.86; P = .40).

Conclusions

TIR was independently associated with mortality in critically ill patients, particularly those with good antecedent glucose control.

Key Words

diabetes
dysglycemia
glucose
glucose variation
intensive insulin therapy

Abbreviations

HbA1c
glycosylated hemoglobin
ICD-9
International Classification of Diseases, Ninth Revision
IQR
interquartile range
TIR
time in targeted blood glucose range

Cited by (0)

FUNDING/SUPPORT: The authors have reported to CHEST that no funding was received for this study.